Oslo, 10 February 2021: Ultimovacs ASA (“Ultimovacs”, ticker ULTI), a pharmaceutical company developing novel immunotherapies against cancer, invites to a webcast presentation of its fourth quarter 2020 results on Wednesday 17 February 2021.
The presentation can be followed as a live webcast (access through link https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20210217_7) at 09:00 CET on Wednesday 17 November 2021. The webcast presentation will be available on our website, and it will be possible to post questions during the presentation through the webcast.
The report and presentation will be available on the company website from 08:00 CET the same day.
For further information, please visit www.ultimovacs.com or contact:
Carlos de Sousa, CEO Email: email@example.com Phone: +47 908 92507
Hans Vassgård Eid, CFO Email: firstname.lastname@example.org Phone: +47 482 48632